ATP5PO and trisomy 21: With the exception of the ATP5O gene, all the genes taken to validation step displayed significant differential expression in the anticipated direction (7 DE genes from chromosome 21 with fold change values ranging from around 1.2-2.2), while for LAMB3 consistent down-regulation was observed in trisomy 21 samples with fold change values estimated at 0.09.